$27.5M Settlement Approved, Ending Shareholders’ Suit Over Pharmaceutical Merger
SAN FRANCISCO — A federal judge in California granted final approval to a $27.5 million settlement among a pharmaceutical company, its former chief executive and shareholders who alleged that the company...To view the full article, register now.
Already a subscriber? Click here to view full article